MERREM Drug Patent Profile

When do Merrem patents expire, and what generic alternatives are available?

Merrem is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in MERREM is meropenem. There are thirty-two drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the meropenem profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Merrem

A generic version of MERREM was approved as meropenem by ACS DOBFAR on October 26^th, 2011.

Summary for MERREM

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	84
Clinical Trials:	15
Patent Applications:	5,317
Drug Prices:	Drug price information for MERREM
What excipients (inactive ingredients) are in MERREM?	MERREM excipients list
DailyMed Link:	MERREM at DailyMed

See drug prices for MERREM

Recent Clinical Trials for MERREM

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Wake Forest University Health Sciences	Phase 4
Johns Hopkins University	Phase 2
Hoffmann-La Roche	Phase 1

See all MERREM clinical trials

US Patents and Regulatory Information for MERREM

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer	MERREM	meropenem	INJECTABLE;INJECTION	050706-001	Jun 21, 1996	AP	RX	Yes	Yes
Pfizer	MERREM	meropenem	INJECTABLE;INJECTION	050706-003	Jun 21, 1996	AP	RX	Yes	Yes

Expired US Patents for MERREM

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	MERREM	meropenem	INJECTABLE;INJECTION	050706-001	Jun 21, 1996
Pfizer	MERREM	meropenem	INJECTABLE;INJECTION	050706-003	Jun 21, 1996

International Patents for MERREM

See the table below for patents covering MERREM around the world.

Country	Patent Number	Title	Estimated Expiration
Japan	H0352466
Japan	S601186	NOVEL BETA-LACTAM COMPOUND AND ITS PREPARATION
Japan	S60166683	NOVEL BETA-LACTAM COMPOUND AND ITS PREPARATION
Germany	3486382
Japan	S60104088	NOVEL BETA-LACTAM COMPOUND AND ITS PREPARATION
Japan	H0466872

Supplementary Protection Certificates for MERREM

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2603514	2019/018	Ireland		PRODUCT NAME: A COMBINATION OF VABORBACTAM, AND/OR A SALT AND/OR HYDRATE THEREOF, AND MEROPENEM, AND/OR A SALT AND/OR HYDRATE THEREOF, IN PARTICULAR MEROPENEM TRIHYDRATE; REGISTRATION NO/DATE: EU/1/18/1334 20181120
2603514	CA 2019 00015	Denmark		PRODUCT NAME: EN KOMBINATION AF VABORBACTAM, OG/ELLER ET SALT OG/ELLER HYDRAT DERAF, OG MEROPENEM, OG/ELLER ET SALT OG/ELLER HYDRAT DERAF, SAERLIGT MEROPENEM TRIHYDRAT; REG. NO/DATE: EU/1/18/1334 20181122
3412676	PA2020519,C3412676	Lithuania		PRODUCT NAME: VABORBAKTAMO IR (ARBA) JO DRUSKOS, IR (ARBA) HIDRATO BEI MEROPENEMO IR (ARBA) JO DRUSKOS, IR (ARBA) HIDRATO, YPAC MEROPENEMO TRIHIDRATO, DERINYS; REGISTRATION NO/DATE: EU/1/18/1334 20181120
3412676	LUC00168	Luxembourg		PRODUCT NAME: COMBINAISON DE VABORBACTAM, ET/OU D'UN SEL ET/OU D'UN HYDRATE DE CELUI-CI, ET DE MEROPENEME, ET/OU D'UN SEL ET/OU D'UN HYDRATE DE CELUI-CI, EN PARTICULIER DE MEROPENEME TRIHYDRATE; AUTHORISATION NUMBER AND DATE: EU/1/18/1334 20181122
2603514	SPC/GB19/021	United Kingdom		PRODUCT NAME: VABORBACTAM, AND/OR A SALT AND/OR HYDRATE THEREOF, AND MEROPENEM, AND/OR A SALT AND/OR HYDRATE THEREOF, IN PARTICULAR MEROPENEM TRIHYDRATE.; REGISTERED: UK EU/1/18/1334 (NI) 20181120; UK PLGB 16239/0061 20181120
2603514	C201930022	Spain		PRODUCT NAME: COMBINACION DE VABORBACTAM, Y/O UNA SAL Y/O UN HIDRATO DEL MISMO, Y MEROPENEM, Y/O UNA SAL Y/O UN HIDRATO DEL MISMO, EN PARTICULAR MEROPENM TRIHIDRATO; NATIONAL AUTHORISATION NUMBER: EU/1/18/1334; DATE OF AUTHORISATION: 20181120; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/18/1334; DATE OF FIRST AUTHORISATION IN EEA: 20181120